USA - NASDAQ:PRTG - VGG7185A1369 - Common Stock
ChartMill assigns a Buy % Consensus number of 43% to PRTG. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-01-08 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-11-29 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-09-07 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-31 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-01 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2022-12-01 | HC Wainwright & Co. | Maintains | Buy |
| 2022-11-30 | Oppenheimer | Maintains | Outperform |
| 2022-09-20 | HC Wainwright & Co. | Maintains | Buy |
| 2022-03-07 | HC Wainwright & Co. | Initiate | Buy |
| 2021-09-21 | Oppenheimer | Initiate | Outperform |
| 2021-09-02 | B. Riley Securities | Initiate | Buy |
| 2021-08-19 | Cantor Fitzgerald | Initiate | Overweight |
The consensus rating for PORTAGE BIOTECH INC (PRTG) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
The number of analysts covering PORTAGE BIOTECH INC (PRTG) is 6.